Preclinical NO / angiogenesis / tendon and GI biology · Peptide
Evidence gap: Route-specific human PK and absolute bioavailability are not established in the imported material.
Open in the interactive library →Compare with other compounds →
Rat tendon research does not establish human SC tendon treatment.
Context: Rat surgical model; PMID 14554208.
Limitations: Route, species and injury model prevent direct transfer to human KLOW dosing.
Distinct protocol, timing or sequence preserved from the saved research material. Unreported fields remain unknown.
Context: Rat · Surgical Achilles transection model
Animal study regimen: Amount: 10 mcg/kg; Frequency: Once daily; Duration: Assessments through day 14; Timing: Beginning 30 minutes after surgery; Route: IP; Species: Rat; Population: Surgical Achilles transection model
Limitations: Animal intraperitoneal treatment cannot establish a human SC tendon or KLOW regimen.
Distinct protocol, timing or sequence preserved from the saved research material. Unreported fields remain unknown.
Context: Rat · Surgical Achilles transection model
Animal study regimen: Amount: 10 ng/kg; Frequency: Once daily; Duration: Assessments through day 14; Timing: Beginning 30 minutes after surgery; Route: IP; Species: Rat; Population: Surgical Achilles transection model
Limitations: Animal intraperitoneal treatment cannot establish a human SC tendon or KLOW regimen.
Distinct protocol, timing or sequence preserved from the saved research material. Unreported fields remain unknown.
Context: Rat · Surgical Achilles transection model
Animal study regimen: Amount: 10 pg/kg; Frequency: Once daily; Duration: Assessments through day 14; Timing: Beginning 30 minutes after surgery; Route: IP; Species: Rat; Population: Surgical Achilles transection model
Limitations: Animal intraperitoneal treatment cannot establish a human SC tendon or KLOW regimen.
Distinct protocol, timing or sequence preserved from the saved research material. Unreported fields remain unknown.
Context: Attributed research context; population or formulation not fully specified.
Attributed proposal / anecdote: Amount: 400 mcg; Frequency: Daily; Route: Not documented
Limitations: Author-reported community schedule, not a validated treatment regimen or personal recommendation. Cycling, rotation and adjunct superiority are not established. Missing fields are not inferred.
These compounds share an Atlas pathway label. That is a navigation connection, not evidence of equivalent effects or suitability together.
Browse this pathway in the library →Educational research summary. Study amounts are research context, not a dose recommendation. Not medical advice.